Topamax Linked To Birth Defects

On March 4th of 2010, the FDA announced that new data showed that women who take Topamax during pregnancy are at an increased risk of giving birth to a child with a cleft lip or a cleft palate.  Topamax and Topiramate (the generic equivalent of Topamax) were approved by the FDA to treat certain types


FDA Took Years To Process Topamax Birth Defect Data

It wasn’t until March of 2011 that the FDA issued a warning that linked Topamax with cleft palate and cleft lip birth defects.  But back in July of 2008, a study linked the drug to those very defects: For the study, researchers examined women who became pregnant while taking topiramate either on its own or along